ImmuPharma (LON:IMM) Shares Up 13.9% – Here’s What Happened

ImmuPharma plc (LON:IMM) shares rose 13.9% during trading on Wednesday . The company traded as high as GBX 15.15 ($0.21) and last traded at GBX 12.67 ($0.17). Approximately 50,412,297 shares traded hands during trading, an increase of 548% from the average daily volume of 7,783,485 shares. The stock had previously closed at GBX 11.13 ($0.15).

ImmuPharma Stock Up 19.5%

The stock has a market cap of £64.81 million, a P/E ratio of -1,457.19 and a beta of 1.53. The business has a 50 day moving average price of GBX 2.88 and a 200 day moving average price of GBX 2.86.

ImmuPharma (LON:IMM) last released its earnings results on Wednesday, August 6th. The company reported GBX (0.38) EPS for the quarter. ImmuPharma had a net margin of 3,519.56% and a negative return on equity of 131.41%. On average, research analysts expect that ImmuPharma plc will post -339.0000022 earnings per share for the current fiscal year.

About ImmuPharma

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.